The University of Chicago Header Logo

Connection

S. Murray Sherman to Hypoglycemic Agents

This is a "connection" page, showing publications S. Murray Sherman has written about Hypoglycemic Agents.
Connection Strength

0.105
  1. No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial. Diabetes Care. 2018 03; 41(3):620-622.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.